The invention discloses a
nucleic acid aptamer AS2-3 of a
human thrombin protein and a
screening method and application thereof. The sequence of the
nucleic acid aptamer AS2-3 is shown in SEQ ID NO:1. The
screening method comprises the following steps: on the basis of a
human thrombin protein aptamer obtained by previous screening, retaining its specific sequence for
library construction, performing
primary screening by using a Capture-SELEX method, and then performing screening again by using a transcription process of a
cell-free transcription and
translation system. The invention successfully obtains a
nucleic acid aptamer sequence AS2-3 which can not only specifically bind to the
human thrombin protein, but also can respond to 0.5 μM human
thrombin protein in a
cell-free transcription process in the form of a linear or
plasmid, and inhibit and regulate the transcription of a downstream
gene. By combining the two screening methods, it is expected that the nucleic acid aptamer AS2-3 can be applied to the screening of aptamer sequences of other target ligands, thereby having the opportunity to replace transcription regulatory factors as
gene elements and be applied to biological circuits for regulation.